Cart
sales@molnova.com
NY-BR-1 p904 A2
CAS No. 347142-73-8
NY-BR-1 p904 A2( —— )
Catalog No. M30248 CAS No. 347142-73-8
T-cell clones specific for this NY-BR-1 epitope (p904) can recognize breast tumor cells expressing NY-BR-1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameNY-BR-1 p904 A2
-
NoteResearch use only, not for human use.
-
Brief DescriptionT-cell clones specific for this NY-BR-1 epitope (p904) can recognize breast tumor cells expressing NY-BR-1.
-
DescriptionT-cell clones specific for this NY-BR-1 epitope (p904) can recognize breast tumor cells expressing NY-BR-1.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number347142-73-8
-
Formula Weight975.14
-
Molecular FormulaC43H78N10O15
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Ser}{Leu}{Ser}{Lys}{Ile}{Leu}{Asp}{Thr}{Val}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Wang W, et al. Recognition of breast cancer cells by CD8+ cytotoxic T-cell clones specific for NY-BR-1. Cancer Res. 2006 Jul 1;66(13):6826-33.
molnova catalog
related products
-
Ganoderic acid C6
Ganoderic acid C6 has antinociceptive activity.
-
Mogroside II-A2
Mogroside II-A2 is a natural product from Siraitia grosvenorii Swingle. Mogrosides exhibit antioxidant, antidiabetic and anticancer activities.
-
Cyaonoside A
The roots of Cyathula officinalis.
